Brüush Oral Care Receives Additional Delisting Threat Over Audit Committee Non-Compliance
Brüush Oral Care Receives Additional Delisting Threat Over Audit Committee Non-Compliance
This deficiency will be considered by the Hearings Panel (the "Panel") at a hearing that has been scheduled for April 25, 2024 (the "Hearing") to address the Company's other current deficiencies.
听证小组（“小组”）将在定于2024年4月25日举行的听证会（“听证会”）上考虑这一缺陷，以解决公司当前的其他缺陷。
As previously reported on May 8, 2023, due to the resignation of one of the Company's board members from its Board of Directors and therefore its Audit Committee on April 12, 2023, the Company no longer complied with the Audit Committee Requirements. Pursuant to Listing Rule 5605(c)(4), Nasdaq provided the Company a cure period to regain compliance with the Audit Committee Requirements, which ended on April 12, 2024.
正如先前在2023年5月8日报道的那样，由于公司的一名董事会成员于2023年4月12日辞去董事会乃至审计委员会的职务，公司不再遵守审计委员会的要求。根据上市规则5605（c）（4），纳斯达克为公司提供了补救期，以恢复对审计委员会要求的遵守，该要求于2024年4月12日结束。